Maritza Guzman
NPI 1942840087ActiveIndividual· Nurse Practitioner· El Paso, TX
Nurse Practitioner in El Paso, Texas, licensed in TX, with an NPI issued in January 2020. Part D covered 336 prescriptions written in 2024, 91% of them generic. Calliditas Therapeutics US Inc. reported $38.05 in payments in 2024, mostly food and beverage.
Overview
| NPI | 1942840087 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Sole proprietor | No |
| NPI issued | Jan 7, 2020 |
| Last updated in NPPES | Jan 7, 2020 |
| Certified by provider | Jan 7, 2020 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Nurse Practitioner Primary | 363L00000X | F09191455 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Nurse Practitioner (AZ) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 336 · 728 30-day fills |
|---|---|
| Patients | 122 |
| Total drug cost | $18,223 |
| Generic share | 91% of claims |
Industry payments (Open Payments)
- 2024$38.05 · 2 payments from 1 company
Top paying companies in 2024
| Company | Amount | Payments |
|---|---|---|
| Calliditas Therapeutics US Inc. | $38.05 | 2 |
What the 2024 payments were for
- Food and Beverage$38.05 · 2 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other nurse practitioners in El Paso
- 1134616063
- 1144709023
- 1144797093
- 1144826199
- 1154752004
- 1194781864
- 1326062845
- 1326507740
- 1326760851
- 1346810736
- 1356717490
- 1477002509
All 131 nurse practitioners in El Paso · All nurse practitioners in Texas